tradingkey.logo

Canada's Northwest Healthcare Q2 revenue falls nearly 17%

ReutersAug 12, 2025 9:13 PM


Overview

  • Northwest Healthcare Q2 2025 revenue falls 16.9% to C$99 million due to asset sales

  • Net income for Q2 2025 reaches C$32.6 mln, reversing prior year loss

  • Co suspends DRIP and appoints CEO Zachary Vaughan to Board


Outlook

  • Company manages rent deferral with Healthscope, expecting repayment by March 2026


Result Drivers

  • ASSET SALES - Revenue decreased 16.9% in Q2 2025 due to non-core asset sales, partially offset by same property revenue growth

  • SPNOI GROWTH - Same Property Net Operating Income increased by 2.8% driven by inflationary rent adjustments and improved recoveries

  • DEBT REDUCTION - Proceeds from asset sales used to repay debt, reducing leverage to 48.5% from 50.0% at year-end 2024


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Net Income

C$32.62 mln

Q2 FFO Per Share

C$0.11


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the specialized reits peer group is "buy."

  • Wall Street's median 12-month price target for Northwest Healthcare Properties REIT is C$5.55, about 14.2% above its August 11 closing price of C$4.76

Press Release: ID:nNFC5HMZvh

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI